Please login to the form below

Not currently logged in
Email:
Password:

DiCE Molecules

This page shows the latest DiCE Molecules news and features for those working in and with pharma, biotech and healthcare.

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi bets on DiCE to find oral alternatives to injectable drugs

Sanofi has made a small-molecule discovery engine developed by US biotech DiCE Molecules a core part of its R&D portfolio. ... DiCE's approach to drug discovery focuses on targeting protein-protein interactions that to date have only been addressed with

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Acquisition – division. $5, 869. DiCE Molecules/ Sanofi. Technology platform to select and optimise drug-like ligands targeting a range of therapeutic areas. ... Acquisition of royalty rights. $1, 140. Blueprint Medicines/ Roche. Small molecules

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics